Post-sign-off events in infectious disease consultation and the incidence of nonadherence to infectious disease recommendations in the post-sign-off period: A retrospective cohort study.
Journal
Antimicrobial stewardship & healthcare epidemiology : ASHE
ISSN: 2732-494X
Titre abrégé: Antimicrob Steward Healthc Epidemiol
Pays: England
ID NLM: 9918266096106676
Informations de publication
Date de publication:
2023
2023
Historique:
received:
30
11
2022
revised:
19
01
2023
accepted:
20
01
2023
entrez:
24
3
2023
pubmed:
25
3
2023
medline:
25
3
2023
Statut:
epublish
Résumé
Infectious diseases (ID) consultation has contributed to improving outcomes in hospitalized patients. However, the timing of signing off on ID consultation varies, depending on the consulting ID physician. We studied the descriptive epidemiology of treatment-related adverse events (ADEs) occurring after the ID physician has signed off on consultation and the epidemiology and predictors of nonadherence to ID recommendations in the post-sign-off period. This retrospective cohort study was conducted at a Japanese tertiary-care center. All patients who received ID consultation between January and December 2019 and treatment recommendations for a confirmed or suspected infectious disease were included. The incidence of any treatment-related ADE after signing off, nonadherence to the final ID recommendations, and factors associated with nonadherence to the ID recommendations were identified. In total, 367 patients receiving ID consultation were included. The incidence of post-sign-off events during index hospitalization was 59 (16.1%) of 367, with antimicrobial-associated ADEs accounting for 26 events (44.1%) and HAIs accounting for 13 events (22.0%). After excluding patients who discontinued treatment, nonadherence to ID recommendations was identified in 55 (15.7%) of 351 patients. Newly acquired HAIs during the index hospitalization after signing off on ID consultation was an independent risk factor for nonadherence to ID recommendations (adjusted odds ratio, 3.78; 95% confidence interval, 1.14-12.52). Post-sign-off events were common and led to nonadherence to ID recommendations during the post-sign-off period. Because this nonadherence occurs for various reasons, patients may require continued attention after signing off to ensure their safety.
Identifiants
pubmed: 36960090
doi: 10.1017/ash.2023.121
pii: S2732494X23001213
pmc: PMC10028937
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e38Informations de copyright
© The Author(s) 2023.
Déclaration de conflit d'intérêts
All the authors declare no conflicts of interest related to this article.
Références
Clin Microbiol Infect. 2008 Apr;14 Suppl 3:15-21
pubmed: 18318875
BMC Health Serv Res. 2015 Dec 01;15:531
pubmed: 26626729
Open Forum Infect Dis. 2018 Mar 15;5(3):ofy026
pubmed: 29577058
Infection. 2012 Oct;40(5):501-7
pubmed: 22723076
Emerg Infect Dis. 2008 Nov;14(11):1722-30
pubmed: 18976555
Health Expect. 2018 Feb;21(1):41-56
pubmed: 28898930
QJM. 2015 Apr;108(4):273-7
pubmed: 25078411
Int J Antimicrob Agents. 2013 Mar;41(3):203-12
pubmed: 23127482
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
Clin Infect Dis. 2016 Dec 7;64(5):558-564
pubmed: 27927865
Chest. 2009 Nov;136(5):1237-1248
pubmed: 19696123
Curr Infect Dis Rep. 2019 Feb 2;21(1):2
pubmed: 30710181
J Antimicrob Chemother. 2010 Jan;65(1):156-62
pubmed: 19910328
BMC Health Serv Res. 2018 Jul 4;18(1):521
pubmed: 29973258
Clin Infect Dis. 2004 May 1;38(9):1212-8
pubmed: 15127330
BMC Infect Dis. 2012 Nov 09;12:292
pubmed: 23140210
Antimicrob Resist Infect Control. 2017 Dec 6;6:124
pubmed: 29225798
Infection. 2013 Dec;41(6):1121-8
pubmed: 23925637
Antibiotics (Basel). 2022 Jan 13;11(1):
pubmed: 35052975
JAMA Netw Open. 2020 Feb 5;3(2):e1921048
pubmed: 32049296
JAMA Intern Med. 2017 Sep 1;177(9):1308-1315
pubmed: 28604925